Botox Rival
Crown Laboratories to Acquire Botox Rival Revance Therapeutics for $924M
Crown Laboratories, Revance Therapeutics, Botox rival, Daxxify, acquisition, private deal, skincare company
Actionable Insights Powered by AI
Crown Laboratories, Revance Therapeutics, Botox rival, Daxxify, acquisition, private deal, skincare company